LOGIN TO YOUR ACCOUNT

Username
Password
Remember Me
Or use your Academic/Social account:

CREATE AN ACCOUNT

Or use your Academic/Social account:

Congratulations!

You have just completed your registration at OpenAire.

Before you can login to the site, you will need to activate your account. An e-mail will be sent to you with the proper instructions.

Important!

Please note that this site is currently undergoing Beta testing.
Any new content you create is not guaranteed to be present to the final version of the site upon release.

Thank you for your patience,
OpenAire Dev Team.

Close This Message

CREATE AN ACCOUNT

Name:
Username:
Password:
Verify Password:
E-mail:
Verify E-mail:
*All Fields Are Required.
Please Verify You Are Human:
fbtwitterlinkedinvimeoflicker grey 14rssslideshare1
Black, C. (Corrinda); Bagust, A.; Boland, A.; Walker, S.; McLeod, C.; De Verteuil, R. (Robyn); Ayres, J. G.; Bain, L. (Lynda); Thomas, Sian; Godden, D. J. (David John); Waugh, Norman (2006)
Publisher: National Coordinating Centre for Health Technology Assessment
Languages: English
Types: Article
Subjects: RC0254
Screening for lung cancer has been the subject of\ud debate for the past three decades. This has largely\ud stemmed from the results of chest X-ray screening\ud studies where improvements in survival were\ud obtained but without reductions in disease-specific,\ud or total, mortality. The debate raises two issues:\ud the design of studies to evaluate screening for\ud lung cancer, in particular the choice of\ud comparator; and the potential role of overdiagnosis of well-differentiated, slow-growing\ud tumours that would not have led to symptoms or\ud death in the lifetime of the affected patient.\ud Lung cancer is the leading cause of death from\ud cancer in the UK, killing approximately 34,000\ud people per year. By the time symptoms develop,\ud the tumour is often at an advanced stage and the\ud prognosis is bleak. Treatment at a less advanced\ud stage of disease with surgical resection has been\ud shown to substantially reduce mortality. \ud Screening would be attractive if it could detect\ud presymptomatic lung cancer at a stage when\ud surgical intervention is feasible.
  • No references.
  • No related research data.
  • No similar publications.

Share - Bookmark

Cite this article